Treatment of depressions resistant to tricyclic antidepressants, related drugs or MAO-inhibitors by lithium addition: review of the literature
- PMID: 2682691
- DOI: 10.1055/s-2007-1014602
Treatment of depressions resistant to tricyclic antidepressants, related drugs or MAO-inhibitors by lithium addition: review of the literature
Abstract
Although it might be premature to consider the efficacy of lithium addition in patients unresponsive to conventional antidepressant drug treatment as established, the evidence is suggestive. Besides 26 open studies, four out of six controlled investigations reported a positive effect of combined therapy administered in the indicated sequence. Three controlled studies confirmed the original observation of de Montigny et al. that improvement may occur within 48 hours. Successful lithium addition was reported in different types of depression and after pretreatment with tricyclic antidepressants, related compounds or MAO-inhibitors. Preliminary recommendations with respect to the practical use of lithium addition are made.
Similar articles
-
[Antidepressive agents in the elderly].Tijdschr Gerontol Geriatr. 1990 Dec;21(6):259-67. Tijdschr Gerontol Geriatr. 1990. PMID: 1980385 Review. Dutch.
-
Combination therapy using moclobemide with tricyclic and tetracyclic antidepressants to treat therapy-resistant depression.Pharmacopsychiatry. 1997 May;30(3):93-6. doi: 10.1055/s-2007-979489. Pharmacopsychiatry. 1997. PMID: 9211570 Clinical Trial.
-
[Treatment of refractory primary depression].Ned Tijdschr Geneeskd. 1997 Jul 12;141(28):1375-9. Ned Tijdschr Geneeskd. 1997. PMID: 9380197 Dutch.
-
Treatment of endogenous depressions resistant to tricyclic antidepressants or related drugs by lithium addition. Results of a placebo-controlled double-blind study.Pharmacopsychiatry. 1989 Sep;22(5):183-7. doi: 10.1055/s-2007-1014603. Pharmacopsychiatry. 1989. PMID: 2682692 Clinical Trial.
-
Reversible monoamine oxidase-A inhibitors in resistant major depression.Clin Neuropharmacol. 1993;16 Suppl 2:S69-76. Clin Neuropharmacol. 1993. PMID: 8313400 Review.
Cited by
-
Review of clinically important drug interactions with lithium.Drug Saf. 1994 Jun;10(6):455-63. doi: 10.2165/00002018-199410060-00004. Drug Saf. 1994. PMID: 7917074 Review.
-
Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression.Psychopharmacology (Berl). 1995 Sep;121(1):27-37. doi: 10.1007/BF02245589. Psychopharmacology (Berl). 1995. PMID: 8539339 Review.
-
Initial lithium augmentation improves the antidepressant effects of standard TCA treatment in non-resistant depressed patients.Psychopharmacology (Berl). 1995 Mar;118(2):223-5. doi: 10.1007/BF02245845. Psychopharmacology (Berl). 1995. PMID: 7617812 Clinical Trial.
-
Therapeutic options for treatment-resistant depression.CNS Drugs. 2010 Feb;24(2):131-61. doi: 10.2165/11530280-000000000-00000. CNS Drugs. 2010. PMID: 20088620 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources